Pulmonary embolism special scenario pregnancy

Resident Survival Guide

Pulmonary Embolism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pulmonary Embolism from other Diseases
Epidemiology and Demographics
Risk Factors
Triggers
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria
Assessment of Clinical Probability and Risk Scores
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores
History and Symptoms
Physical Examination
Laboratory Findings
Arterial Blood Gas Analysis
D-dimer
Biomarkers
Electrocardiogram
Chest X Ray
Ventilation/Perfusion Scan
Echocardiography
Compression Ultrasonography
CT
MRI
Treatment
Treatment approach
Medical Therapy
IVC Filter
Pulmonary Embolectomy
Pulmonary Thromboendarterectomy
Discharge Care and Long Term Treatment
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Follow-Up
Support group
Special Scenario
Pregnancy
Cancer
Trials
Landmark Trials
Case Studies
Case #1
Pulmonary embolism special scenario pregnancy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pulmonary embolism special scenario pregnancy
CDC on Pulmonary embolism special scenario pregnancy
Pulmonary embolism special scenario pregnancy in the news
Blogs on Pulmonary embolism special scenario pregnancy
Directions to Hospitals Treating Pulmonary embolism special scenario pregnancy
Risk calculators and risk factors for Pulmonary embolism special scenario pregnancy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Special Scenario

Pregnancy

• LMWH is the preferred treatment. (Grade 1C)
• Warfarin is contraindicated.
  • Embryopathy is at increased risk at 6 - 12 weeks. (Grade 2C)
• Continue anticoagulation for 6 weeks or more postpartum. (Grade 1C)
• Heparin and warfarin are safe for nursing infants.

Cancer

• The recurrence rate of pulmonary emboli is 30% after a year.
• For treatment LMWH is recommended for the first 3 - 6 months.(Grade 1A)
• Later, warfarin can be used after 3-6 months.
• Anticoagulation should be continued.